TOPLINE:

Patients with autoimmune Addison disease (AAD) showed increased use of hypnotics/sedatives, anxiolytics, and antidepressants in the year before diagnosis, suggesting potential misdiagnosis of early symptoms. The elevated use of hypnotics/sedatives persisted for years after diagnosis, indicating persistent sleep disturbances in this population.

METHODOLOGY:

Researchers in Sweden conducted a population-based cohort study to assess the use of psychotropic drugs among patients with AAD (n = 963; median age at diagnosis, 40.8 years; 57.9% women) and matched control individuals from the general population (n = 9366).

The outcome was at least one annual dispensation of antipsychotics, anxiolytics, hypnotics/sedatives, and/or antidepressants from 3 years before to 3 years after the

See Full Page